Gabriele Giliberti
Gabriele Giliberti publishes mostly in Organic Chemistry, Molecular Biology and Infectious Diseases, on topics such as Synthesis and biological activity, Synthesis and Biological Evaluation and HIV/AIDS drug development and treatment.
- World rank
- #2,682,018 of 7,710,434 ranked researchers
- Rank in Italy
- #90,309 of 242,206
- Works
- 63
- Citations
- 1.3k
- Citations per work
- 20.3
What does Gabriele Giliberti research?
Gabriele Giliberti's work is mostly in Chemistry (34%), Medicine (22%), Biochemistry, Genetics and Molecular Biology (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2134.0%
- Chemistry2134.0%
- Everything else1930.0%
- Health Sciences1421.7%
- Medicine1421.7%
- Life Sciences914.3%
- 1Organic Chemistry34% of their works
- 2Molecular Biology10% of their works
- 3Infectious Diseases9% of their works
- 4Epidemiology8% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Plant Science4% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- HIV/AIDS drug development and treatment
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- HIV Research and Treatment
- Quinazolinone synthesis and applications
- Viral Infections and Immunology Research
Which keywords describe Gabriele Giliberti's research?
The keywords of their largest research topics: Heterocyclic Compounds, Medicinal Chemistry, Biological Evaluation, Synthesis, Antiretroviral Therapy, Tubulin Inhibitors, Vascular Targeting Agents and Drug Discovery.
- Viral Infection
- Myocarditis
- HIV
- Triazines
- Copper-Catalyzed Cycloaddition
- HIV Infection
- Quinoxaline
- Antimicrobial
- Drug Discovery
- Tubulin Inhibitors
- Synthesis
- Medicinal Chemistry
- Heterocyclic Compounds
- Biological Evaluation
- Antiretroviral Therapy
- Vascular Targeting Agents
- Anticancer
- Antimicrobial Activity
- Drug Resistance
- Click Chemistry
- Scaffold
- AIDS
- Indirubin
- Quinazoline
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Heterocyclic Compounds262 topics
- Medicinal Chemistry262 topics
- Biological Evaluation243 topics
- Synthesis243 topics
- Antiretroviral Therapy162 topics
- Tubulin Inhibitors151 topic
- Vascular Targeting Agents151 topic
- Drug Discovery142 topics
- Anticancer132 topics
- Antimicrobial132 topics
- Antimicrobial Activity111 topic
- Quinoxaline111 topic
- Drug Resistance101 topic
- HIV Infection101 topic
- Click Chemistry71 topic
- Copper-Catalyzed Cycloaddition71 topic
- Scaffold71 topic
- Triazines71 topic
- AIDS61 topic
- HIV61 topic
- Indirubin61 topic
- Myocarditis61 topic
- Quinazoline61 topic
- Viral Infection61 topic
Where does Gabriele Giliberti work?
Gabriele Giliberti's main affiliation in the publication record is University of Cagliari, Italy.
How many publications and citations does Gabriele Giliberti have?
OpenAlex counts 63 works and 1,281 citations for Gabriele Giliberti, an h-index of 20, ranking #2,682,018 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gabriele Giliberti. Posts are plain text and can be reported.